REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/01/2025
Back to search
Official data from USPTO
GOPREVY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
09/02/2025
Trademark type
Word
Nice classes
5
Filing date
02/19/2020
Registration date
09/01/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/01/2020
Last transaction
09/02/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
LAVACHE, LINDA
Law office
L60
Current location
PETITIONS OFFICE
Holders and representatives
Holders
Glaxo Group Limited
Representatives
Christopher Hanes GSK
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of blood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; all of the foregoing expressly excluding vaccinespharmaceutical preparations for the prevention and/or treatment of infectious diseases and disorderspharmaceutical preparations for the prevention and/or treatment of pneumococcal disease and/or pneumonia
Publications
History of USPTO decisions and trademark events.
22 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/30/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/28/2023
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
03/09/2021
GPNX
NOTIFICATION PROCESSED BY IB
11/13/2020
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/01/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/28/2020
FIMP
FINAL DISPOSITION PROCESSED
10/28/2020
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
10/01/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
09/01/2020
CHPB
POST PUBLICATION AMENDMENT - ENTERED
06/22/2020
APET
ASSIGNED TO PETITION STAFF
06/17/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/16/2020
PUBO
PUBLISHED FOR OPPOSITION
06/16/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/27/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
05/19/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/13/2020
DOCK
ASSIGNED TO EXAMINER
05/07/2020
MAFR
APPLICATION FILING RECEIPT MAILED
04/11/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/07/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
04/04/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/02/2020
Continuous trademark protection
Get notified about every new filing that threatens GOPREVY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.